Javascript must be enabled to continue!
ASSA13-03-40 The Study of Cardiomyocytes Gene Modified by Recombinant Adeno-Associated Virus-9 Combined with PDGF-B in Vitro
View through CrossRef
Objective
To explore the feasibility, safety and anti-apoptosis of using recombinant adeno-associated virus-9 which contained platelet-derived growth factor-B (rAAV9-PDGF-B) transduction to rat cardiomyocytes in vitro.
Methods
The primary neonatal rat cardiomyocytes were isolated and cultured, and cardiomyocytes were transduced with rAAV9-PDGF-B at MOI (multiplicities of infection) = 5 × 105, and collected cardiomyocytes from different times after transduction, respectively at1, 3, 6, 14, 21, 28 days. Proteins were extracted from the cells for Western Blot analyse and observed the expression of PDGF-B, the transfection efficiency were measured by cell immunofluorescence. Alamar Blue assays were used to evaluate the safety of rAAV9-PDGF-B transduction to cardiomyocytes. And explore the cardiomyocytes which over expressed PDGF-B whether own the capacity of protecting cells against H2O2 –induced apoptosis by the test of apoptosis-related proteins and the ratio of Tunel-positive cell.
Results
Cardiomyocytes were over expressed PDGF-B at the third day after transduction, and the expression of PDGF-B was increased gradually. After days 5, the expression would be stable and sustaining, such expression can last for 28 days. Cell immunofluorescence showed that approximately 78.6% cardiomyocytes overexpressed PDGF-B at days 6 after transduction. Alamar Blue assays, which evaluated the toxicity of rAAV9-PDGF-B transduction to cardiomyocytes, showed that the reduction ratios of cardiomyocytes at different times were all close to 1.0. Moreover, in Cardiomyocytes which over expressed PDGF-B, H2O2 –induced apoptosis was accompanied by the down-regulation of Bax and Tunel-positive cells, by the up-regulation of Bcl-2 and P-Akt, there was no difference between group PDGF-B+ H2O2 (P > 0.05).
Conclusions
rAAV9-PDGF-B could effectively transduce cardiomyocytes cultured in vitro and persistently express PDGF-B at least 28 days. rAAV9-PDGF-B was no significant toxic effects on cardiomyocytes. Furthermore, the cardiomyocytes which over expressed PDGF-B also own the capacity of protecting cells against H2O2 –induced apoptosis, these effects might be mediated by phosphorylation of Akt signalling in cardiomyocytes.
Title: ASSA13-03-40 The Study of Cardiomyocytes Gene Modified by Recombinant Adeno-Associated Virus-9 Combined with PDGF-B in Vitro
Description:
Objective
To explore the feasibility, safety and anti-apoptosis of using recombinant adeno-associated virus-9 which contained platelet-derived growth factor-B (rAAV9-PDGF-B) transduction to rat cardiomyocytes in vitro.
Methods
The primary neonatal rat cardiomyocytes were isolated and cultured, and cardiomyocytes were transduced with rAAV9-PDGF-B at MOI (multiplicities of infection) = 5 × 105, and collected cardiomyocytes from different times after transduction, respectively at1, 3, 6, 14, 21, 28 days.
Proteins were extracted from the cells for Western Blot analyse and observed the expression of PDGF-B, the transfection efficiency were measured by cell immunofluorescence.
Alamar Blue assays were used to evaluate the safety of rAAV9-PDGF-B transduction to cardiomyocytes.
And explore the cardiomyocytes which over expressed PDGF-B whether own the capacity of protecting cells against H2O2 –induced apoptosis by the test of apoptosis-related proteins and the ratio of Tunel-positive cell.
Results
Cardiomyocytes were over expressed PDGF-B at the third day after transduction, and the expression of PDGF-B was increased gradually.
After days 5, the expression would be stable and sustaining, such expression can last for 28 days.
Cell immunofluorescence showed that approximately 78.
6% cardiomyocytes overexpressed PDGF-B at days 6 after transduction.
Alamar Blue assays, which evaluated the toxicity of rAAV9-PDGF-B transduction to cardiomyocytes, showed that the reduction ratios of cardiomyocytes at different times were all close to 1.
Moreover, in Cardiomyocytes which over expressed PDGF-B, H2O2 –induced apoptosis was accompanied by the down-regulation of Bax and Tunel-positive cells, by the up-regulation of Bcl-2 and P-Akt, there was no difference between group PDGF-B+ H2O2 (P > 0.
05).
Conclusions
rAAV9-PDGF-B could effectively transduce cardiomyocytes cultured in vitro and persistently express PDGF-B at least 28 days.
rAAV9-PDGF-B was no significant toxic effects on cardiomyocytes.
Furthermore, the cardiomyocytes which over expressed PDGF-B also own the capacity of protecting cells against H2O2 –induced apoptosis, these effects might be mediated by phosphorylation of Akt signalling in cardiomyocytes.
Related Results
Functional Regulation of Adipose-Derived Stem Cells by PDGF-D
Functional Regulation of Adipose-Derived Stem Cells by PDGF-D
Abstract
Platelet-derived growth factor-D (PDGF-D) was recently identified, and acts as potent mitogen for mesenchymal cells. PDGF-D also induces cellular transforma...
PDGF-BB and Its Role in Megakaryopoiesis and Thrombocythemia
PDGF-BB and Its Role in Megakaryopoiesis and Thrombocythemia
Abstract
Background: Essential Thrombocythemia (ET) is characterized by persistently elevated platelet counts in the context of a normal red cell mass. However, the ...
CONSTRUCTION OF RECOMBINANT ADENO-ASSOCIATED VIRUS SEROTYPE 9 WITH RIBOZYME GENE TARGETING NF-κB AND ITS SUPPRESSION OF NF-κB ACTIVITY IN HELA CELLS
CONSTRUCTION OF RECOMBINANT ADENO-ASSOCIATED VIRUS SEROTYPE 9 WITH RIBOZYME GENE TARGETING NF-κB AND ITS SUPPRESSION OF NF-κB ACTIVITY IN HELA CELLS
Objectives
To construct the recombinant adeno-associated virus serotype 9 containing ribozyme gene (R65) targeting nuclear factor-κ B (NF-κB), and investigate the...
GW24-e2369 Aliskiren inhibits proliferation of vascular smooth muscle cells induced by platelet-derived growth factor-BB via extracellular regulated protein kinases signal pathway
GW24-e2369 Aliskiren inhibits proliferation of vascular smooth muscle cells induced by platelet-derived growth factor-BB via extracellular regulated protein kinases signal pathway
Objectives
To identify the effect of direct renin inhibitor aliskiren on proliferation of vascular smooth muscle cells (VSMCs) induced by PDGF-BB, and study the m...
Angiotensin II Stimulates Platelet-Derived Growth Factor-B Chain Expression in Newborn Rat Vascular Smooth Muscle Cells and Neointimal Cells Through Ras, Extracellular Signal–Regulated Protein Kinase, and c-Jun N-Terminal Protein Kinase Mechanisms
Angiotensin II Stimulates Platelet-Derived Growth Factor-B Chain Expression in Newborn Rat Vascular Smooth Muscle Cells and Neointimal Cells Through Ras, Extracellular Signal–Regulated Protein Kinase, and c-Jun N-Terminal Protein Kinase Mechanisms
Abstract
—Platelet-derived growth factors (PDGFs) have been implicated in the pathogenesis of vascular proliferative disorders. Vascular smooth muscle cells (VSMCs) are...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Transforming growth factor-β1 regulates platelet-derived growth factor receptor β subunit in human liver fat-storing cells
Transforming growth factor-β1 regulates platelet-derived growth factor receptor β subunit in human liver fat-storing cells
Activated liver fat-storing cells (FSC) are known to play a key role in the development of liver fibrosis. An important element in FSC activation process is the increased expressio...

